For the treatment of advanced lung adenocarcinoma, molecular driven therapeutic targets have resulted in a paradigm shift. However, in early non-small cell lung cancer (NSCLC), surgical resection remains the treatment of choice with adjuvant chemotherapy. In a recent study published in the April 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) iJournal of Thoracic Oncology/i, researchers identified patterns of mutations in ...Tuesday, 26 March 2013
Researchers Identified Patterns of Mutations in Lung Adenocarcinoma
For the treatment of advanced lung adenocarcinoma, molecular driven therapeutic targets have resulted in a paradigm shift. However, in early non-small cell lung cancer (NSCLC), surgical resection remains the treatment of choice with adjuvant chemotherapy. In a recent study published in the April 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) iJournal of Thoracic Oncology/i, researchers identified patterns of mutations in ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment